Innospec price to free cash flow IOSP

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 34.7×
10-year median: 21.9×
Against its 10-year history: 82nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 11.4× to 105×
Peer median: 24.8×

Innospec's price to free cash flow is 34.7× as of Oct 23, 2026.

That is above its ten-year median of 21.9×, higher than on 82% of days in the last ten years.

Over that time it ranged from 11.4× in Mar 2020 to 105× in Oct 2017.

The median for 10 chemicals stocks of a similar size is 24.8×.

Price to free cash flow over time

median 21.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	34.7×	18.6×	39.1×
2025	35.4×	14.2×	35.4×
2024	14.9×	14.3×	22.1×
2023	19.7×	16.2×	85.8×
2022	76.5×	41.9×	82.8×
2021	47.2×	15.9×	49.0×
2020	19.0×	11.4×	19.0×
2019	17.9×	15.1×	32.4×
2018	26.9×	22.0×	55.1×
2017	52.9×	16.5×	105×
2016	17.1×	9.3×	18.0×
2015	10.7×	9.3×	14.0×
2014	14.1×	13.6×	55.9×
2013	57.3×	11.9×	59.6×
2012	10.9×	10.0×	18.4×

Against its peers

Companies in Chemicals nearest Innospec's size, closest first, today.

Company	Price to free cash flow
IOSPInnospec	34.7×
NGVTIngevity	15.5×
ROGRogers	27.0×
FULFuller H B	26.7×
WDFCWD 40	35.9×
AVNTAvient	19.7×
CBTCabot	13.6×
CRONCronos	24.8×
CSWCSW Industrials	33.4×
BCPCBalchem	n/m
HXLHexcel	23.6×
Peer median	24.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Innospec

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.